Could this pill beat long COVID fatigue?
Symptom relief
Recruiting now
This phase II trial tests whether the drug sonlicromanol can reduce fatigue in 80 people with long COVID who experience post-exertional malaise (worsening symptoms after activity). Participants take the drug or a placebo twice daily for 13 weeks, and researchers measure changes i…
Phase: PHASE2 • Sponsor: Michele van Vugt • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC